Metastatic melanoma of unknown primary is a rare entity with low life expectancy. Inoperable metastatic malignant melanoma in lungs has a survival rate of <6%. Regression of the primary lesion is a well-documented theory in the literature, since melanoma is one of the tumours that can undergo regression. We present a case of a young man with metastatic malignant melanoma in lungs, whose survival duration is longer than expected even without metastasectomy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543345 | PMC |
http://dx.doi.org/10.1136/bcr-2012-006283 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!